Flexible Flat-Rate Plans
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
DrugPatentWatch Database Preview
Hikma Farmaceutica Company Profile
« Back to Dashboard
Summary for Applicant: Hikma Farmaceutica
| Patents: | 0 |
| Tradenames: | 39 |
| Ingredients: | 33 |
| NDAs: | 43 |
| Drug Master File Entries: (click here to view) | 19 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma Farmaceutica | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065238-002 | Mar 12, 2010 | RX | No | ||||||||||||||||||||||
Hikma Farmaceutica | CEFOXITIN | cefoxitin sodium | INJECTABLE;INJECTION | 065239-001 | Mar 2, 2010 | RX | No | ||||||||||||||||||||||
Hikma Farmaceutica | BUTORPHANOL TARTRATE | butorphanol tartrate | INJECTABLE;INJECTION | 078400-002 | May 1, 2009 | RX | No | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Similar Applicant Names
Here is a list of applicants with similar names.
« Back to Dashboard
For more information try a trial or see the database preview and plans and pricing
How are People Using DrugPatentWatch?
For patent and exclusivity due dligience
— Pharma investment firm, USA
To get information on brands we work on currently or could potentially work on
— Marketing professional, USA
To know more about patents of drug products and drug substances
— Manager, formulation R&D, India
To study patents on drugs in selected therapeutic areas
— Pharmaceutical process development, India
To get paragraph IV challenges, detailed regulatory status and tentative approvals
— Dosage form R&D services company, India
For data on generic availability, patent expirations, legal action that postpones generic launch
— Clinical pharmacist, USA
To analyze generic candidates using patent expiration data
— Portfolio management, Indonesia
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639
